Skip to main content

Articles

Page 68 of 108

  1. Mammalian relative of DnaJ (MRJ [DNAJB6]), a novel member of the human DnaJ family, has two isoforms. The smaller isoform, MRJ(S), is studied mainly for its possible role in Huntington's disease. There are no ...

    Authors: Aparna Mitra, Rebecca A Fillmore, Brandon J Metge, Mathur Rajesh, Yaguang Xi, Judy King, Jingfang Ju, Lewis Pannell, Lalita A Shevde and Rajeev S Samant
    Citation: Breast Cancer Research 2008 10:R22
  2. Estrogen receptors (ERs) play key roles in breast cancer development and influence treatment outcome in breast cancer patients. Identification of molecules that regulate ER function may facilitate development ...

    Authors: Yiyu Zou, Wen-Bin Tsai, Chien-Jui Cheng, Chiun Hsu, Young Min Chung, Pao-Chen Li, Sue-Hwa Lin and Mickey CT Hu
    Citation: Breast Cancer Research 2008 10:R21
  3. Brain metastases (BM) occur in up to one third of patients with metastatic breast cancer (MBC), whose incidences and prognoses by breast cancer subtypes in BM have not been well delineated.

    Authors: Byung-Ho Nam, Sun Young Kim, Hye-Sook Han, Youngmee Kwon, Keun Seok Lee, Tae Hyun Kim and Jungsil Ro
    Citation: Breast Cancer Research 2008 10:R20
  4. Efforts are ongoing to determine the significance of unclassified variants (UVs) in the breast cancer susceptibility genes BRCA1/BRCA2, but no study has systematically assessed whether women carrying the suspecte...

    Authors: Eunjung Lee, Roberta McKean-Cowdin, Huiyan Ma, Zhengjia Chen, David Van Den Berg, Brian E Henderson, Leslie Bernstein and Giske Ursin
    Citation: Breast Cancer Research 2008 10:R19
  5. While current breast cancer chemoprevention strategies using selective estrogen response modulators and aromatase inhibitors are quite successful, their effects are limited to hormonally responsive breast canc...

    Authors: Stephan Woditschka, Jill D Haag, Bob Mau, Ronald A Lubet and Michael N Gould
    Citation: Breast Cancer Research 2008 10:R18
  6. Finding new immunohistochemical markers that are specific to hereditary breast cancer could help us to select candidates for BRCA1/BRCA2 mutation testing and to understand the biological pathways of tumour develo...

    Authors: Hannaleena Eerola, Mira Heinonen, Päivi Heikkilä, Outi Kilpivaara, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Ari Ristimäki and Heli Nevanlinna
    Citation: Breast Cancer Research 2008 10:R17
  7. Estrogen and androgen signalling pathways exert opposing influences on the proliferation of mammary epithelial and hormone-dependent breast cancer cells. We previously reported that plasma concentrations of 1,...

    Authors: Michel Aubé, Christian Larochelle and Pierre Ayotte
    Citation: Breast Cancer Research 2008 10:R16
  8. Oestrogen exposure is a central factor in the development of breast cancer. Oestrogen receptor alpha (ESR1) is the main mediator of oestrogen effect in breast epithelia and has also been shown to be activated ...

    Authors: Kristjana Einarsdóttir, Hatef Darabi, Yi Li, Yen Ling Low, Yu Qing Li, Carine Bonnard, Arvid Sjölander, Kamila Czene, Sara Wedrén, Edison T Liu, Per Hall, Keith Humphreys and Jianjun Liu
    Citation: Breast Cancer Research 2008 10:R15
  9. The introduction of high-throughput technologies, also called -omics technologies, into epidemiology has raised the need for high-quality observational studies to reduce several sources of error and bias.

    Authors: Vanessa Dumeaux, Anne-Lise Børresen-Dale, Jan-Ole Frantzen, Merethe Kumle, Vessela N Kristensen and Eiliv Lund
    Citation: Breast Cancer Research 2008 10:R13
  10. Individuals with germline mutations in the BRCA1 gene have an elevated risk of developing breast cancer, and often display characteristic clinicopathological features. We hypothesised that inactivation of BRCA1 b...

    Authors: Cameron Snell, Michael Krypuy, Ee Ming Wong, Maurice B Loughrey and Alexander Dobrovic
    Citation: Breast Cancer Research 2008 10:R12
  11. Adenine nucleotide translocator (ANT) 2 is highly expressed in proliferative cells, and ANT2 induction in cancer cells is known to be directly associated with glycolytic metabolisms and carcinogenesis. In addi...

    Authors: Ji-Young Jang, Yun Choi, Yoon-Kyung Jeon and Chul-Woo Kim
    Citation: Breast Cancer Research 2008 10:R11
  12. Historically, histomorphological and epidemiological data suggested that atypical ductal hyperplasia and ductal carcinoma in situ are the earliest recognizable neoplastic stages of breast cancer progression. Over...

    Authors: Sharon Moulis and Dennis C Sgroi
    Citation: Breast Cancer Research 2008 10:302
  13. Osteolytic metastases due to breast cancer are serious events. The interactions between breast cancer cells with the microenvironment of bone have been thought to provide an ideal milieu for cancer cells. Rece...

    Authors: Lorenz C Hofbauer, Tilman Rachner and Shiv K Singh
    Citation: Breast Cancer Research 2008 10:101
  14. Overexpression of the ERBB2 oncogene is observed in about 20% of human breast tumors and is the consequence of increased transcription rates frequently associated with gene amplification. Several studies have sho...

    Authors: Abdelkader Allouche, Gregory Nolens, Annalisa Tancredi, Laurence Delacroix, Julie Mardaga, Viviana Fridman, Rosita Winkler, Jacques Boniver, Philippe Delvenne and Dominique Y Begon
    Citation: Breast Cancer Research 2008 10:R9
  15. Various perinatal factors, including birth weight, birth order, maternal age, gestational age, twin status, and parental smoking, have been postulated to affect breast cancer risk in daughters by altering the ...

    Authors: Sue Kyung Park, Daehee Kang, Katherine A McGlynn, Montserrat Garcia-Closas, Yeonju Kim, Keun Young Yoo and Louise A Brinton
    Citation: Breast Cancer Research 2008 10:R8
  16. Aberrant microenvironment and endoplasmic reticulum (ER) stress are associated with solid-tumor progression. Stress proteins, like heat shock proteins and glucose-regulated proteins, are frequently overexpress...

    Authors: Jiao Wang, Hui Hua, Yuliang Ran, Hongyin Zhang, Weiping Liu, Zhihua Yang and Yangfu Jiang
    Citation: Breast Cancer Research 2008 10:R7
  17. Our understanding of many aspects of cancer biology has been advanced through the use of modern genetics. These studies have already shown that germ line polymorphisms play a significant role in disease initia...

    Authors: James M Rae, Todd C Skaar, Susan G Hilsenbeck and Steffi Oesterreich
    Citation: Breast Cancer Research 2008 10(Suppl 1):301

    This article is part of a Supplement: Volume 10 Supplement 1

  18. Primary breast cancer involving four or more axillary lymph nodes carries a poor prognosis. We hypothesized that use of an immunohistochemical biomarker scoring system could allow for identification of variabl...

    Authors: Simon J Crabb, Chris D Bajdik, Samuel Leung, Caroline H Speers, Hagen Kennecke, David G Huntsman and Karen A Gelmon
    Citation: Breast Cancer Research 2008 10:R6
  19. The gene encoding Na+/H+ exchanger regulatory factor 1 (NHERF1) is a putative tumor suppressor gene that harbors frequent loss of heterozygosity (LOH) and intragenic mutations in breast carcinoma. The exact biolo...

    Authors: Yong Pan, Edward J Weinman and Jia Le Dai
    Citation: Breast Cancer Research 2008 10:R5
  20. Bisphosphonates have become standard therapy for the treatment of skeletal complications related to breast cancer. Although their therapeutic effects mainly result from an inhibition of osteoclastic bone resor...

    Authors: Fabrice Journé, Naïma Kheddoumi, Carole Chaboteaux, Hugues Duvillier, Guy Laurent and Jean-Jacques Body
    Citation: Breast Cancer Research 2008 10:R4
  21. Breast cancer patients with HER2/neu overexpression have poor outcomes with a decrease in disease-free survival (DFS) and overall survival. The biology of HER2/neu overexpression in breast tumors in African-Am...

    Authors: Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Dennis Slamon and Jaydutt V Vadgama
    Citation: Breast Cancer Research 2008 10:R3
  22. There is now extensive evidence that mammographic density is an independent risk factor for breast cancer that is associated with large relative and attributable risks for the disease. The epidemiology of mamm...

    Authors: Lisa J Martin and Norman F Boyd
    Citation: Breast Cancer Research 2008 10(Suppl 1):201

    This article is part of a Supplement: Volume 10 Supplement 1

  23. The HER (human EGFR related) family of receptor tyrosine kinases (HER1/EGFR (epidermal growth factor receptor)/c-erbB1, HER2/c-erbB2, HER3/c-erbB3 and HER4/c-erbB4) shares a high degree of structural and funct...

    Authors: Andrea Sassen, Justine Rochon, Peter Wild, Arndt Hartmann, Ferdinand Hofstaedter, Stephan Schwarz and Gero Brockhoff
    Citation: Breast Cancer Research 2008 10:R2
  24. Gangliosides are sialic acid containing glycosphingolipids that are ubiquitously distributed on vertebrate plasma membranes. GM3, a precursor for most of the more complex ganglioside species, is synthesized by...

    Authors: Yuchao Gu, Junhua Zhang, Wenyi Mi, Jing Yang, Feng Han, Xinzhi Lu and Wengong Yu
    Citation: Breast Cancer Research 2008 10:R1
  25. Obesity is a risk factor for postmenopausal breast cancer and is associated with shortened mammary tumor (MT) latency in MMTV-TGF-α mice with dietary-induced obesity. One link between obesity and breast cancer...

    Authors: Soner Dogan, Xin Hu, Yan Zhang, Nita J Maihle, Joseph P Grande and Margot P Cleary
    Citation: Breast Cancer Research 2007 9:R91
  26. Recently, unprecedented drops in breast cancer incidence have been reported for populations of mostly White European descent. Incidence patterns in non-White racial/ethnic groups are less described. Therefore,...

    Authors: Amelia K Hausauer, Theresa HM Keegan, Ellen T Chang and Christina A Clarke
    Citation: Breast Cancer Research 2007 9:R90

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions